Wistuba II - Search Results

1

Genomic heterogeneity of multiple synchronous lung cancer.

Liu Y, Zhang J, Li L, Yin G, Zhang J, Zheng S, Cheung H, Wu N, Lu N, Mao X, Yang L, Zhang J, Zhang L, Seth S, Chen H, Song X, Liu K, Xie Y, Zhou L, Zhao C, Han N, Chen W, Zhang S, Chen L, Cai W, Li L, Shen M, Xu N, Cheng S, Yang H, Lee JJ, Correa A, Fujimoto J, Behrens C, Chow CW, William WN, Heymach JV, Hong WK, Swisher S, Wistuba II, Wang J, Lin D, Liu X, Futreal PA, Gao Y. Liu Y, et al. Among authors: wistuba ii. Nat Commun. 2016 Oct 21;7:13200. doi: 10.1038/ncomms13200. Nat Commun. 2016. PMID: 27767028 Free PMC article.

2

Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.

Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar J. Huang J, et al. Ann Diagn Pathol. 2001 Dec;5(6):321-9. doi: 10.1053/adpa.2001.29338. Ann Diagn Pathol. 2001. PMID: 11745069

3

Clonality of combined tumors.

Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J. Huang J, et al. Among authors: wistuba ii. Arch Pathol Lab Med. 2002 Apr;126(4):437-41. doi: 10.5858/2002-126-0437-COCT. Arch Pathol Lab Med. 2002. PMID: 11900568 Free article.

4

Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.

Tang X, Wu W, Sun SY, Wistuba II, Hong WK, Mao L. Tang X, et al. Among authors: wistuba ii. Mol Cancer Res. 2004 Dec;2(12):685-91. Mol Cancer Res. 2004. PMID: 15634757

5

EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, Gazdar AF, Wistuba II. Tang X, et al. Among authors: wistuba ii. Cancer Res. 2005 Sep 1;65(17):7568-72. doi: 10.1158/0008-5472.CAN-05-1705. Cancer Res. 2005. PMID: 16140919

6

Application of a methylation gene panel by quantitative PCR for lung cancers.

Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hol B, Prinsen C, Thunnissen FB, Gazdar AF. Shivapurkar N, et al. Among authors: wistuba ii. Cancer Lett. 2007 Mar 8;247(1):56-71. doi: 10.1016/j.canlet.2006.03.020. Epub 2006 Apr 27. Cancer Lett. 2007. PMID: 16644104 Free PMC article.

7

Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications.

Prudkin L, Wistuba II. Prudkin L, et al. Among authors: wistuba ii. Ann Diagn Pathol. 2006 Oct;10(5):306-15. doi: 10.1016/j.anndiagpath.2006.06.011. Ann Diagn Pathol. 2006. PMID: 16979526 Review.

8

Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.

Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB, Wistuba II. Tang X, et al. Among authors: wistuba ii. Cancer. 2006 Dec 1;107(11):2637-46. doi: 10.1002/cncr.22315. Cancer. 2006. PMID: 17078054 Free article.

9

Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.

Shen J, Behrens C, Wistuba II, Feng L, Lee JJ, Hong WK, Lotan R. Shen J, et al. Among authors: wistuba ii. Cancer Res. 2006 Dec 1;66(23):11194-206. doi: 10.1158/0008-5472.CAN-04-1444. Cancer Res. 2006. PMID: 17145864

10

Genetics of preneoplasia: lessons from lung cancer.

Wistuba II. Wistuba II. Curr Mol Med. 2007 Feb;7(1):3-14. doi: 10.2174/156652407779940468. Curr Mol Med. 2007. PMID: 17311529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters